Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Buhl (Mainz, Germany). Pharmacological options for the treatment of COPD: present and future. Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy

Member's Comments

No comment yet.

Related content which might interest you: Treatment of COPD: from pharmacological to instrumental therapies Source: Eur Respir Rev 2009; 19: 7-23 Year: 2010 Current opinion: Pharmacological approaches in asthma and COPD Source: Breathe 2009; 6: 24-35 Year: 2009 Pharmacological treatment & current controversies in COPD Source: ERS Course 2019 - Masterclass in airways disease 2019 Year: 2019 Filling the gaps: future treatment options for mild asthma Source: International Congress 2018 – The complexities of managing mild asthma Year: 2018 Who should receive which biologic and why? Current and future approaches in severe asthma patients Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what? Year: 2021 COPD and new treatment options: the role of primary care Source: International Congress 2014 – Primary Care Programme "Management of COPD and other respiratory conditions in clinical practice" Year: 2014 Chronic cough: Are we integrating non-pharmacological therapies into treatment plans? Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017 Pharmacological treatment & current controversies in asthma Source: ERS Course 2019 - Masterclass in airways disease 2019 Year: 2019 Recommendations of new therapies for severe asthma and the future Source: Annual Congress 2013 –ERS/ATS Task Force report on severe asthma Year: 2013 Other options of prevention - the current state and the future Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches Year: 2003 The future of COPD treatment: what are the difficulties in and barriers to drug development for COPD Source: Annual Congress 2011 - Lancet / ERS symposium - New frontiers in COPD Year: 2011 Treatment of moderate persistent asthma: new options Source: Annual Congress 2007 - Pharmacological treatment of mild to moderate persistent asthma: new approaches Year: 2007 What is the scientific and clinical rationale? Triple therapy in COPD patients Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what? Year: 2021 Rational monitoring of COPD: where do current clinical guidelines stand? Source: Eur Respir J 2007; 29: 1078-1081 Year: 2007 Treatment of interstitial lung diseases: current approaches and future directions Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options Year: 2021 Future directions: preventing and treating asthma Source: International Congress 2016 – Childhood wheeze: are we making any progress? Year: 2016